Marit Arnes

Levonorgestrel‐impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial

Anne Ørbo, AB Vereide, Marit Arnes et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2013 · 139 citations · Full text

Medicine, Gynecology, Obstetrics +13

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

AB Vereide, Marit Arnes, Bjørn Straume et al. · Gynecologic Oncology · 2003 · 104 citations

Medicine, Gynecology, Nuclear Medicine +15

Treatment results of endometrial hyperplasia after prospective D-score classification

Anne Ørbo, Marit Arnes, Christine Hancke et al. · Gynecologic Oncology · 2008 · 97 citations

Medicine, Gynecology, Pathology +8

Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-α and ER-β) in human endometrial hyperplasia

Anne Beate Vereide, Turid Kaino, Georg Sager et al. · Gynecologic Oncology · 2005 · 94 citations

Medicine, Endocrinology, Pharmacology +14

Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens

Anne Ørbo, Marit Arnes, AB Vereide et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2015 · 53 citations · Full text

Medicine, Gynecology, Reproductive Medicine +12